MedTrace Logo

Changes in Pain, Spasticity, and Quality of Life After Use of Counterstrain Treatment in Individuals With SCI

NCT05559255 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2024-08-06

No results posted yet for this study

Summary

Individuals with spinal cord injury (SCI) often suffer from pain and spasticity. Traditional treatments for both of these conditions have been medications. However, it has been suggested that the counterstrain osteopathic manual manipulation treatment can decrease pain and possibly spasticity. The aim of this study is to investigate the effects of counterstrain osteopathic manual manipulation treatment on pain and spasticity in individuals with SCI.

Conditions

  • Pain
  • Spasticity, Muscle
  • Quality of Life

Interventions

OTHER

Counterstrain manual manipulative treatment

The steps required to perform counterstrain in any region of the body are as follows: 1. Find the tender point. 2. Assess the tenderness using a pain scale. 3. Passively and gently place the patient in a position-of-comfort that results in the greatest reduction of tenderness at the tender point. Approximate the position first, then fine-tune through small arcs of movement. Aim to achieve at least 70% tenderness reduction, with the goal of 100%. 4. Maintain the position for 90 seconds while continuing to monitor the patient's tender point. 5. Passively return the patient to a neutral position. 6. Re-test for tenderness at the tender point.

Sponsors & Collaborators

  • American Osteopathic Association

    collaborator OTHER

  • William Carey University

    lead OTHER

Principal Investigators

  • Italo Subbarao, DO · William Carey University

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-09
Primary Completion
2024-03-31
Completion
2024-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05559255 on ClinicalTrials.gov